References 

1.  Hucklebridge F, The diurnal patterns of the adrenal steroids cortisol and dehydroepiandrosterone (DHEA) in relation to awakening. Psychoneuroendocrinology. 2005 Jan;30(1):51-7.

2.  Butenandt A. et Dannenbaum H., Z physiol, Vol. 229, 192. 1934.

3.  Berr C, et al. Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: A French community-based study. Proc. Natl. Acad. Sci. USA Vol. 93, pp. 13410-13415, November 1996. Population Biology

4.  Barrett-Connor E, A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease., NEJM, Volume 315:1519-1524, December 11, 1986, Number 24

5.  Feldman, HA et al, Low Dehydroepiandrosterone and Ischemic Heart Disease in Middle-aged Men: Prospective Results from the Massachusetts Male Aging Study American Journal of Epidemiology Vol. 153, No. 1 : 79-89

6.  Muller M, Endogenous Sex Hormones and Cardiovascular Disease in Men. , The Journal of Clinical Endocrinology & Metabolism Vol. 88, No. 11 5076-5086

7.  Muller M, Endogenous sex hormones and metabolic syndrome in aging men.
J Clin Endocrinol Metab. 2005 May;90(5):2618-23. Epub 2005 Feb 1.

 8.  Nakamura S, Possible Association of Heart Failure Status With Synthetic Balance Between Aldosterone and Dehydroepiandrosterone in Human Heart.  , Circulation, 2004;110:1787-1793 

9.  Osorio A, Gutierrez MA, Ortega E, Ruiz-Requena E, Dehydroepiandrosterone sulfate and growth axis hormones in patients with ischemic heart disease. Horm Res. 2002;57(5-6):165-9.

10.  Cawood E, Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med. 1996 Sep;26(5):925-36.

11.  Barrett-Conner E, Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study. J Am Geriatr Soc. 1999 Jun;47(6):685-91

12.  Bloch M, Dehydroepiandrosterone treatment of midlife dysthymia.
Biol Psychiatry. 1999 Jun 15;45(12):1533-41.

13.  Double-blind treatment of major depression with dehydroepiandrosterone.
Wolkowitz O, Am J Psychiatry. 1999 Apr;156(4):646-9.

14.  Schmidt P,et al, Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression.   Arch Gen Psychiatry. 2005 Feb;62(2):154-62.

15.  Deuschle M. et al, Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine. Neuropsychobiology. 2004;50(3):252-6.

16.  Hedman M, Low sulpho-conjugated steroid hormone levels in systemic lupus erythematosus (SLE,  Clin Exp Rheumatol. 1989 Nov-Dec;7(6):583-8.

17.  Straub R, J  Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. Clin Endocrinol Metab. 1998 Jun;83(6):2012-7

18.  Kozora E, Laudenslager M, Lemieux A, West SG, Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J Int Neuropsychol Soc. 2001 Sep;7(6):745-54.

19.  Liu C, Chin, Effects of sex hormones on apoptosis in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Med J (Engl). 2001 Mar;114(3):291-3.198

20.  Verthelyi D, Petri M, Ylamus M, Klinman DM, Disassociation of sex hormone levels and cytokine production in SLE patients. Lupus. 2001;10(5):352-8

21.  Chang D, Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial., Arthritis Rheum. 2002 Nov;46(11):2924-7.

22.  Vollenhoven R, Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Van Expert Opin Pharmacother. 2002 Jan;3(1):23-31.

23.  Van Vollenhoven R, Dehydroepiandrosterone in systemic lupus erythematosus. Rheum Dis Clin North Am. 2000 May;26(2):349-62.

24.  Andus T, Aliment,  Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Pharmacol Ther. 2003 Feb;17(3):409-14.

25.  Cutolo M, Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest. 2002;25(10 Suppl):19-23.

26.  Tabata N, Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch Dermatol Res. 1997 Jun;289(7):410-4.

27.  Kannisto S, Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression during inhaled steroid therapy in adult asthmatic patients. Eur J Endocrinol. 2004 May;150(5):687-90

28.  Hampson G, Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis. Metabolism. 2002 Nov;51(11):1458-62.

29.  Osmanagaoglu MA, Okumus B, Osmanagaoglu T, Bozkaya H. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women. J Womens Health (Larchmt). 2004 Nov;13(9):993-9.

30. Fingerova H, Matlochova J. [Reduced serum dehydroepiandrosterone levels in postmenopausal osteoporosis] Ceska Gynekol. 1998 Apr;63(2):110-3.

31.  Miklos S, Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.Acta Biomed Ateneo Parmense. 1995;66(3-4):139-46.

32.  Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000 Aug;15(8):1526-36.

33.  Tok E, Well maintained endogenous DHEA levels associated with diminished osteoporosis risk:  Maturitas. 2004 Jul 15;48(3):235-42.

34.  Sun Y, Chin, Treatment of osteoporosis in men using dehydroepiandrosterone sulfate. Med J (Engl). 2002 Mar;115(3):402-4.

35.  Labrie F, Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab. 1997 Oct;82(10):3498-505.

36.  Weill-Engerer S, DHEA lowers Beta Amyloid levels. J Clin Endocrinol Metab. 2002 Nov;87(11):5138-43.

37.  Solerte S, DHEA supplementation decreases inflammatory cytokine markers in Alzheimer’s Disease (AD) patients:          Dement Geriatr Cogn Disord. 1999 Jan-Feb;10(1):21.

38.  Carlson L, DHEA showed mild cognitive benefit in AD patients: Horm Behav. 1999 Jun;35(3):254-63.

39.  Wolkowitz O, DHEA supplementation showed no impact in active AD patients:Neurology. 2003 Apr 8;60(7):1071-6.

40.  Reiter W, DHEA levels lower in men with erectile dysfunction (ED):Urology. 2000 May;55(5):755-8

41.  Massachusetts Male Aging Study, DHEA supplementation associated with improvement in erectile function in subjects with ED who had no discernable organic dysfunction and in  men with hypertension: , Urol Res. 2001 Aug;29(4):278-81.

42.  Comstock G, DHEA and prostate cancer: Cancer Epidemiol Biomarkers Prev. 1993 May-Jun;2(3):219-21.

43.  Lasco A, Females and lipid metabolism: Eur J Endocrinol. 2001 Oct;145(4):457-61.

44.  Casson P, Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am J Obstet Gynecol. 1993 Dec;169(6):1536-9.

45.  Murialdo G, et al, Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia. J Endocrinol Invest. 2001 Mar;24(3):139-46.

46.  Huppert FA, Van Niekerk JK., Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst Rev. 2001;(2):CD000304.

47.  Barrett-Connor E, Kritz-Silverstein D, Edelstein SL, A prospective study of dehydroepiandrosterone sulfate (DHEAS) and bone mineral density in older men and women. Am J Epidemiol. 1993 Jan 15;137(2):201-6.

48. Bastianetto S, Ramassamy C, Poirier J, Quirion R.; Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage.  Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):35-41.

49. Reiter WJ, Schatzl G, Mark I, Zeiner A, Pycha A, Marberger M; Dehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologies. Urol Res. 2001 Aug;29(4):278-81.

50.  Nair K.S, et al.  DHEA in Elderly Women and DHEA or Testosterone in Elderly Men.  NEJM 355:16.  Oct. 19, 2006, 1647-1659.

51.   Baulieu EE, et al. DHEA, DHEA sufate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.  Proc Natl Acad Sci USA 2000;97:4279-84.

52.  Yasuda M and Horie S. To the Editor. NEJM 356;6.  Feb. 8, 2007 635-636.